Stay updated on Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the old revision label was removed. The 'Back to Top' element was also removed, which is a minor UI change.
    Difference
    0.2%
    Check dated 2025-09-13T17:43:50.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, v3.0.1, indicating a recent revision. The previous update information has been removed.
    Difference
    0.2%
    Check dated 2025-09-06T15:30:02.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has added a facility name and location details, including specific dates related to recurrent respiratory papillomatosis and pembrolizumab, while removing various location terms and previous dates.
    Difference
    4%
    Check dated 2025-08-30T12:16:08.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:49:56.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T00:20:58.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    1%
    Check dated 2025-08-01T19:39:19.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page.